It appears that cancer cells become enablers of the immune response via the expression of IFN-γ-response genes, triggering the upregulation of antigen presentation, amplification of the interferon response, and induction of chemokines (i.e., CXCL9 and CXCL10) to entice immune cells to the TME. This evidence concerns the gene IFNG and cancer.